journal
MENU ▼
Read by QxMD icon Read
search

Pharmaceutical Patent Analyst

journal
https://www.readbyqxmd.com/read/27848274/is-inherent-disclosure-sufficient-for-priority-claim-monoclonal-versus-chimeric-humanized-antibody-estoppels
#1
Takeshi S Komatani
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27813447/fostering-innovative-product-development-for-neglected-tropical-diseases-through-partnerships
#2
Amy Starr, Katy M Graef, Jennifer Dent
Neglected tropical diseases are a group of infectious diseases that threaten and impact a significant portion of individuals living in low- and middle-income countries. Healthcare product R&D, which has been relatively limited for this group of infectious diseases, is timely and requires significant risk and resource investment by companies. Regardless of these costs, the global community has recognized the impact on human health that developing products for these diseases could have. Incentives, including 'push' and 'pull' funding, and platforms that support sharing of intellectual property through partnerships, such as The World Intellectual Property Organization Re:Search, are driving R&D...
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27813443/validity-studies-enhancing-patent-searches
#3
Sophie Bergeron, James L Grant
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27805847/compulsory-licensing-of-patents-in-india
#4
Rahul Chaudhry
This article deals with compulsory licensing scenarios in India, provides a background of relevant provisions in the Patents Act and examines how these provisions are Trade-Related Aspects of Intellectual Property Rights compliant. This article further discusses the procedure followed by India in granting a compulsory license, provides an overview of compulsory license applications filed in India to date and judicial precedence regarding the same. This article also highlights how compulsory licensing is a great safeguard that balances the interests of the innovators and the public at large...
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27805846/patent-highlights-june-july-2016
#5
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27805479/compulsory-licenses-as-a-defense-in-pharmaceutical-and-biotech-patent-litigation
#6
Andreas von Falck
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27804787/pharmaceutical-patent-applications-in-freeze-drying
#7
Edmond Ekenlebie, Tomaž Einfalt, Arianna Irò Karytinos, Andrew Ingham
Injectable products are often the formulation of choice for new therapeutics; however, formulation in liquids often enhances degradation through hydrolysis. Thus, freeze-drying (lyophilization) is regularly used in pharmaceutical manufacture to reduce water activity. Here we examine its contribution to 'state of the art' and look at its future potential uses. A comprehensive search of patent databases was conducted to characterize the international patent landscape and trends in the use of freeze-drying. A total of 914 disclosures related to freeze-drying, lyophilization or drying of solid systems in pressures and temperatures equivalent to those of freeze-drying were considered over the period of 1992-2014...
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27804785/crowdsourcing-in-pharmaceutical-r-d-a-revolutionary-concept-or-nothing-new
#8
Chie Hoon Song
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27804784/update-on-brazil-s-pharma-patent-landscape
#9
Rana Gosain
Brazil's Pharma market is a dynamic and promising one. It ranks within the top ten market. There are peculiar hurdles that patentees have to overcome, such as, a two-tier examination, a serious backlog at the Brazilian Patent and Trademark Office. Several measures to accelerate examination have been adopted given the meager number of Examiners.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27804782/creating-commercial-value-from-patents-the-interplay-between-patent-protection-and-patent-information-management
#10
Chie Hoon Song
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27610753/fluorine-18-patents-2009-2015-part-2-new-radiochemistry
#11
Andrew V Mossine, Stephen Thompson, Allen F Brooks, Alexandra R Sowa, Jason M Miller, Peter Jh Scott
Fluorine-18 ((18)F) is one of the most common positron-emitting radionuclides used in the synthesis of positron emission tomography radiotracers due to its ready availability, convenient half-life and outstanding imaging properties. In Part 1 of this review, we presented the first analysis of patents issued for novel radiotracers labeled with fluorine-18. In Part 2, we follow-up with a focus on patents issued for new radiochemistry methodology using fluorine-18 issued between January 2009 and December 2015.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27610752/surface-modulatable-nanocapsids-for-targeting-and-tracking-toward-nanotheranostic-delivery
#12
Marie Stark, R Holland Cheng
Nanoparticle diagnostics and therapeutics (nanotheranostics) have significantly advanced cancer detection and treatment. However, many nanotheranostics are ineffective due to defects in tumor localization and bioavailability. An engineered Hepatitis E Virus (HEV) nanocapsid is a proposed platform for targeted cancer-cell delivery. Self-assembling from HEV capsid subunits, nanocapsids retain the capacity to enter cells and resist proteolytic/acidic conditions, but lack infectious viral elements. The nanocapsid surface was modified for chemical activation to confer tumor-specific targeting and detection, immune-response manipulation and controlled theranostic delivery...
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27573248/plausibility-in-patent-law-an-unsettled-concept
#13
Constance Crawford, Laura Reynolds
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27573095/how-the-new-patent-trial-and-appeal-board-rules-impact-the-practice-of-inter-partes-reviews
#14
Benjamin C Hsing, Wanda French-Brown
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27572950/trade-secret-protection-in-the-pharma-industry
#15
MaryAnne Armstrong
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27531596/patent-highlights-april-may-2016
#16
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27531460/at-a-glance-the-european-patent-with-unitary-effect
#17
Sebastian Höpfner
Everything is almost ready for a new patent system to come into force in Europe. Its implementation will provide access to a unitary patent and a Unified Patent Court that can be used to centrally enforce and invalidate patents in the relevant member states. This system will provide several advantages and will create a more business-friendly Europe regarding intellectual property rights. However, also some risks are associated with the new system. This article will provide a general overview over this future system and highlight some strategic options that may be considered when assessing patent filing, enforcement and clearance strategies...
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27409277/pharmaceutical-patent-law-expert-perspectives-from-around-the-globe
#18
Takeshi S Komatani
No abstract text is available yet for this article.
July 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27391111/patent-filing-strategies-perspectives-from-the-cooperation-council-for-the-arab-states-of-the-gulf
#19
Nevin Jacob Koshy
The protection and enforcement of intellectual property rights has become one of the most contentious issues in global commerce. Much of the traditional growth and development of countries in the Middle East over the past 30 years or so has come from oil and gas revenues. The main areas that have been covered in this article are: synopsis of patenting system in each country, the Cooperation Council for the Arab States of the Gulf patent filing system, patentability subject matter, prosecution of patent application, opposition and/or invalidation action(s) and issues that need to be resolved for an effective patent regime...
July 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27348790/patent-litigation-in-india-continues-to-throw-up-new-challenges
#20
Prashant Reddy Thikkavarapu
For several years after the reinstitution of a pharmaceutical patent regime in India, most innovator pharmaceutical companies have faced a string of high-profile defeats during litigation in India. In the last 2 years, however, the fortunes of pharmaceutical patentees have changed dramatically. Not only have Indian courts enforced pharmaceutical patents and issued injunctions restraining Indian generic companies from infringing valid patents, but they have also refused to invoke 'public interest' arguments to delay the enforcement of patents...
July 2016: Pharmaceutical Patent Analyst
journal
journal
47821
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"